Papers

1

Total Citations

5

H-Index

1

About

Shengru Wang is a leading authority in pediatric spinal deformity, with a primary focus on congenital scoliosis (CS) and early-onset scoliosis (EOS). Their seminal review, "Advances in the diagnosis and treatment of congenital scoliosis" (2025, 5 citations), synthesizes cutting-edge research on the genetic and environmental origins of vertebral malformations during embryogenesis, offering a comprehensive framework for understanding CS etiology. Wang’s work bridges the gap between molecular mechanisms and clinical application, detailing how recent genetic discoveries—such as key mutations in somitogenesis pathways—are transforming diagnostic precision and therapeutic strategies. By integrating these insights into surgical planning and non-operative management, Wang has advanced personalized treatment protocols that improve outcomes for young patients. Their contributions are particularly impactful in clarifying the complex interplay between genetic predisposition and environmental triggers, providing a roadmap for early intervention. Wang’s research, though nascent in citation count, is already shaping the field’s approach to congenital scoliosis, establishing them as a rising voice in pediatric orthopedics and a key figure in translating basic science into tangible clinical advances.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Advances in the diagnosis and treatment of congenital scoliosis
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago